Endocrine and adrenergic pharmacological intervention in diseases of the prostate

about

Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR A 6-month large-scale study into the safety of tamsulosin Alpha-blockers and lower urinary tract function: more than smooth muscle relaxation?

P2860

Q28209605-9FF7BB62-3344-4A3B-9CF3-937DAE72FE7A Q28367575-8E245429-E2F3-4D99-A889-8158DD5482B5 Q34334931-5C2B87C9-4C77-4BC2-A65A-A5CFD8D32720

P2860

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

Item

http://www.wikidata.org/entity/Q35803015

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

@ast

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

@en

type

Item

label

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

@ast

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

@en

prefLabel

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

@ast

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

@en

P1476

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

@en

P2093

A Rane

http://www.w3.org/2001/XMLSchema#string

P2860

Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism

Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

Structure of human type II 5 alpha-reductase gene

Steroid 5 alpha-reductase 2 deficiency

Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor.

Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer.

P450-dependent enzymes as targets for prostate cancer therapy.

Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase

A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.

P304

329-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2125.1998.T01-1-00688.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229571619

http://www.w3.org/2001/XMLSchema#string

P698

9578179

http://www.w3.org/2001/XMLSchema#string

P932

1873965

http://www.w3.org/2001/XMLSchema#string

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

about

P2860

P2860

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932